Equities research analysts at Wedbush decreased their FY2024 earnings per share (EPS) estimates for Denali Therapeutics in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback